Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Bolt Biotherapeutics (BOLT) Return on Sales (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Return on Sales for 6 consecutive years, with 2.69% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 613.0% to 2.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.37% through Dec 2025, up 445.0% year-over-year, with the annual reading at 4.37% for FY2025, 445.0% up from the prior year.
  • Return on Sales hit 2.69% in Q4 2025 for Bolt Biotherapeutics, up from 3.33% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2.69% in Q4 2025 to a low of 876.42% in Q1 2021.
  • Historically, Return on Sales has averaged 59.44% across 5 years, with a median of 10.3% in 2022.
  • Biggest five-year swings in Return on Sales: plummeted -82378bps in 2021 and later surged 84729bps in 2022.
  • Year by year, Return on Sales stood at 53.46% in 2021, then surged by 73bps to 14.17% in 2022, then skyrocketed by 40bps to 8.57% in 2023, then dropped by -3bps to 8.82% in 2024, then soared by 70bps to 2.69% in 2025.
  • Business Quant data shows Return on Sales for BOLT at 2.69% in Q4 2025, 3.33% in Q3 2025, and 4.77% in Q2 2025.